0001209191-23-039582.txt : 20230626
0001209191-23-039582.hdr.sgml : 20230626
20230626090906
ACCESSION NUMBER: 0001209191-23-039582
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bristol James Arthur
CENTRAL INDEX KEY: 0001715153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40602
FILM NUMBER: 231039576
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC.
STREET 2: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Erasca, Inc.
CENTRAL INDEX KEY: 0001761918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831217027
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 465-6511
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-22
0
0001761918
Erasca, Inc.
ERAS
0001715153
Bristol James Arthur
C/O ERASCA, INC.
3115 MERRYFIELD ROW, SUITE 300
SAN DIEGO
CA
92121
1
0
0
0
0
Stock Option (right to buy)
2.66
2023-06-22
4
A
0
60000
0.00
A
2024-06-22
2033-06-21
Common Stock
60000
60000
D
100% of the options to purchase shares vest on June 22, 2024, subject to the Reporting Person's continuous service to the Issuer on such vesting date.
/s/ Ebun S. Garner, as Attorney-in-Fact
2023-06-26